Pulmonx (LUNG) Accounts Payables (2019 - 2025)

Pulmonx (LUNG) has 7 years of Accounts Payables data on file, last reported at $3.9 million in Q4 2025.

• Accounts Payables for Q4 2025 came in at $3.9 million, up 2.04% year-over-year; the trailing twelve-month figure through Dec 2025 was $3.9 million (up 2.04% YoY), and the FY2025 annual result was $3.9 million, up 2.04% from the prior year.
• Accounts Payables fell to $3.9 million in Q4 2025 per LUNG's latest filing, from $6.4 million in the prior quarter.
• Over five years, Accounts Payables peaked at $6.6 million in Q2 2025 and troughed at $1.5 million in Q4 2023.
• A 5-year average of $3.3 million and a median of $3.0 million in 2023 frame the typical range for Accounts Payables.
• The sharpest annual moves came in 2022 and 2024: Accounts Payables slumped 40.28% in 2022, then soared 155.64% in 2024.
• A 5-year view of Accounts Payables shows it stood at $1.6 million in 2021, then advanced by 11.13% to $1.8 million in 2022, then retreated by 14.85% to $1.5 million in 2023, then soared by 155.64% to $3.8 million in 2024, then rose by 2.04% to $3.9 million in 2025.
• Business Quant data shows LUNG's Accounts Payables at $3.9 million in Q4 2025, $6.4 million in Q3 2025, and $6.6 million in Q2 2025.